These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36574970)

  • 41. Drug-induced and other orofacial-cervical dyskinesias.
    Jankovic J
    Ann Intern Med; 1981 Jun; 94(6):788-93. PubMed ID: 7015951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.
    Koch J; Shi WX; Dashtipour K
    Pharmacol Ther; 2020 Aug; 212():107580. PubMed ID: 32454050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to Letter to the Editor.
    Friedman JH; D'Abreu A
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():630. PubMed ID: 30783554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug-induced movement disorders: tardive syndromes].
    Blayac JP; Pinzani V; Peyrière H; Hillaire-Buys D
    Therapie; 2004; 59(1):113-9. PubMed ID: 15199677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Secondary Chorea: A Review of the Current Literature.
    Feinstein E; Walker R
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():22. PubMed ID: 32775036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. INVOLUNTARY MOVEMENTS FOLLOWING STEREOTACTIC OPERATIONS FOR PARKINSONISM WITH SPECIAL REFERENCE TO HEMI-CHOREA (BALLISMUS).
    HUGHES B
    J Neurol Neurosurg Psychiatry; 1965 Aug; 28(4):291-303. PubMed ID: 14338118
    [No Abstract]   [Full Text] [Related]  

  • 47. [The clinical characteristics of involuntary movements in childhood].
    Nomura Y
    No To Hattatsu; 1997 May; 29(3):199-205. PubMed ID: 9146024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recognition and diagnosis of tardive dyskinesia.
    Klawans HL
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):3-7. PubMed ID: 2858477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Paroxysmal dyskinesias - disorder categories, their causes and treatment].
    Gontarz M; Papuć E; Rejdak K
    Wiad Lek; 2018; 71(5):1056-1060. PubMed ID: 30176640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial.
    Gruber D; Südmeyer M; Deuschl G; Falk D; Krauss JK; Mueller J; Müller JU; Poewe W; Schneider GH; Schrader C; Vesper J; Volkmann J; Winter C; Kupsch A; Schnitzler A;
    Brain Stimul; 2018; 11(6):1368-1377. PubMed ID: 30249417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis.
    Macerollo A; Deuschl G
    J Neurol Sci; 2018 Jun; 389():55-60. PubMed ID: 29433807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.
    Lerner V; Miodownik C
    Curr Psychiatry Rep; 2011 Aug; 13(4):295-304. PubMed ID: 21519907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New approaches in the management of hyperkinetic movement disorders.
    Fahn S
    Adv Exp Med Biol; 1977; 90():157-73. PubMed ID: 303860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Paroxysmal dyskinesias].
    Perona-Moratalla AB; Argandoña L; García-Muñozguren S
    Rev Neurol; 2009 Jan; 48 Suppl 1():S7-9. PubMed ID: 19222019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results.
    Szota AM; Scheel-Krüger J
    Behav Pharmacol; 2020 Sep; 31(6):511-523. PubMed ID: 32459694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5-14 years.
    Krause P; Kroneberg D; Gruber D; Koch K; Schneider GH; Kühn AA
    J Neurol; 2022 Jul; 269(7):3563-3568. PubMed ID: 35083518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Anderson KE; Stamler D; Davis MD; Factor SA; Hauser RA; Isojärvi J; Jarskog LF; Jimenez-Shahed J; Kumar R; McEvoy JP; Ochudlo S; Ondo WG; Fernandez HH
    Lancet Psychiatry; 2017 Aug; 4(8):595-604. PubMed ID: 28668671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential diagnosis of choreiform tardive dyskinesia.
    Hyde TM; Hotson JR; Kleinman JE
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):255-68. PubMed ID: 1821242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.